SRNE News and Press, Sorrento Therapeutics Inc. From 02/13/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Monday.com (NASDAQ: MNDY ) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace. As part of this partnership, Appfire will build out the Mo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Room’s Studio / Shutterstock Sorrento Therapeutics (NASDAQ: SRNE ) stock is falling on Monday after the company filed for bankruptcy alongside subsidiary Scintilla Pharmaceuticals. A filing with t...

COVID-19 drug and vaccine developer Sorrento Therapeutics ( NASDAQ: SRNE ) lost ~28% pre-market Monday after announcing that the company filed for Chapter 11 bankruptcy in a Texas bankruptcy court. More than 416K Sorrento ( SRNE ) shares have already changed hands in the pre-m...

3 Tips for Investing in Penny Stocks For Growth Investing sustainably in penny stocks refers to making investment decisions that prioritize long-term financial stability and growth, while also considering the social and environmental impact of your investments. The goal is to build a portfoli...

ELYXYB TM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. 1 The acute migraine drug market size is expected to reach US$9.26 billion by 2030. 3 There is strong evidence for use of...

PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), an innovative revenue-generating company focused on acquiring, developing and co...

SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (N...

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentoth...

PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questionsȁ...

Summary Shares of Scilex could trade higher due to hedging pressure from large Sorrento short positions. Scilex's equity offering facilities, mean that the price could fall precipitously at any time via company dilution. Scilex's small free float, combined with the two drivers above...